Form D · Biotechnology
Syenex, Inc.
Evanston, IL · CIK 0001935303
Offering snapshot reported Jan 27, 2025 · SEC filing
- Reported sold
- $8.66M Offering amount: $8.66M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 27, 2025 | Initial | $8,662,428 | No comparison | 18 | SEC filing |
| Sep 7, 2022 | Amendment | $5,000,000 | $4,775,000vs Jul 13, 2022 | 14 | SEC filing |
| Jul 13, 2022 | Initial | $225,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-536251
Source: Form D, filed Jan 27, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John D. Rosanelli | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1801 Maple Ave, Suite 6210
Evanston, IL, 60201
Evanston, IL, 60201